Bioethical Aspects of Human Geneticization

• Authors: Marcin Leźnicki

Title variants

IT

Bioethical Aspects of Human Geneticization

PL

Bioetyczne aspekty genetyzacji człowieka

RU

Bioethical Aspects of Human Geneticization

• Languages of publication: EN

Abstracts

RU

Human geneticization, discussed in the following text, is usually associated with the bio-medical practices aimed at human improvement, with the use of genetic enhancement, also understood as genetic improvement or genetic correction. Despite the wide range of benefits claimed by scientists (including biotechnologists and geneticists), these practices undoubtedly generate a number of ethical and legal problems. They concern, among other things, the legitimacy of conducting research in the field of biotechnology or genetics, including reprogenetics, its possible direction, projections related to the development of the research, as well as the methods and means used to control the aforementioned research, or even the problem of both the legislative and moral validity of its further practical implementation. This can be seen, for example, in the ongoing discussion on the geneticization of human life, and in the broader context of its progressive biomedicalization. In view of the considerable breadth and complexity of the issue of geneticization, this text focuses primarily on a closer examination of the possibilities that genetic enhancements, supported by the potential which  genetic engineering might bring,  followed by  due consideration of selected bio-ethical dilemmas that may arise from the application of such enhancements.

PL

Genetyzacja człowieka łączy się z praktykami biomedycznymi, mającymi na celu ulepszanie ludzi poprzez zastosowanie wzmocnień genetycznych, nazywanych także udoskonaleniem genetycznym lub korekcją genetyczną. Pomimo szerokiego wachlarza deklarowanych przez naukowców (w tym biotechnologów i genetyków) korzyści, jakie wynikają z zastosowania wspomnianych praktyk, generują one bezspornie szereg problemów natury etyczno-prawnej. Wątpliwości dotyczą m.in. zasadności prowadzenia prac badawczych w obszarze biotechnologii czy genetyki, w tym reprogenetyki, ich możliwego kierunku, prognoz związanych z rozwojem badań, celowości stosowanych metod i środków kontroli oraz słuszności legislacyjnej i moralnej ich dalszego praktycznego wdrażania. Tego rodzaju wątpliwości potwierdza dyskusja wokół genetyzacji życia ludzkiego, która w szerszym kontekście dotyczy jego postępującej biomedykalizacji. Z uwagi na szerokość i złożoność zagadnienia genetyzacji, w artykule skoncentrowano się przede wszystkim na bliższym prześledzeniu możliwości, jakie mogą potencjalnie przynieść wzmocnienia genetyczne, wsparte potencjałem inżynierii genetycznej. Analizie poddano także wybrane dylematy bioetyczne, które łączą się z wykorzystaniem tego rodzaju wzmocnień.

IT

Human geneticization, discussed in the following text, is usually associated with the bio-medical practices aimed at human improvement, with the use of genetic enhancement, also understood as genetic improvement or genetic correction. Despite the wide range of benefits claimed by scientists (including biotechnologists and geneticists), these practices undoubtedly generate a number of ethical and legal problems. They concern, among other things, the legitimacy of conducting research in the field of biotechnology or genetics, including reprogenetics, its possible direction, projections related to the development of the research, as well as the methods and means used to control the aforementioned research, or even the problem of both the legislative and moral validity of its further practical implementation. This can be seen, for example, in the ongoing discussion on the geneticization of human life, and in the broader context of its progressive biomedicalization. In view of the considerable breadth and complexity of the issue of geneticization, this text focuses primarily on a closer examination of the possibilities that genetic enhancements, supported by the potential which  genetic engineering might bring,  followed by  due consideration of selected bio-ethical dilemmas that may arise from the application of such enhancements.

Keywords

EN

geneticisation; reprogenetics; genetic enhancement; biopower; germ-line therapy

IT

geneticisation; reprogenetics; genetic enhancement; biopower; germ-line therapy; geneticisation; reprogenetics; genetic enhancement; biopower; germ-line therapy

RU

geneticisation; reprogenetics; genetic enhancement; biopower; germ-line therapy

PL

genetyzacja; reprogenetyka; wzmocnienie genetyczne; biowładza; terapia linii zarodkowej; genetyzacja; reprogenetyka; wzmocnienie genetyczne; biowładza; terapia linii zarodkowej

• Publisher: Uniwersytet Kardynała Stefana Wyszyńskiego w Warszawie
• Journal: Studia Ecologiae et Bioethicae
• Year: 2020
• Volume: 18
• Issue: 3
• Pages: 7-17

Dates

published

2020-09-30

Contributors

author

Marcin Leźnicki

References

• Acland, Gregory M., Gustavo D. Aguirre, Jharna Ray, Qi Zhang, Tomas S. Aleman, Artur V. Cideciyan, Susan E. Pearce-Kelling, Vibha Anand, Yong Zeng, Albert M. Maguire, Samuel G. Jacobson, William W. Hauswirth, and Jean Bennett. 2001. “Gene Therapy Restores Vision in a Canine Model of Childhood Blindness.” Nature Genetics 28(1): 92-95. https://doi.org/10.1038/ng0501-92.
• Arribas-Ayllon, Michael. 2016. “After Geneticization.” Social Science & Medicine 159: 132-139. https://doi.org/10.1016/j.socscimed.2016.05.011.
• Baoutina, Anna, Ian E. Alexander, John E. J. Rasko, and Kerry R. Emslie.. 2007. “Potential Use of Gene Transfer in Athletic Performance Enhancement.” Molecular Therapy 15(10): 1751-1766. https://doi.org/10.1038/sj.mt.6300278.
• Bokek-Cohen, Ya'arit. 2016. “How are Marketing Strategies of Genetic Material Used as a Mechanism for Biopolitical Governmentality?” Consumption Markets & Culture 19: 534-554. https://doi.org/10.1080/10253866.2015.1137897.
• Bostrom, Nick. 2003. “Human Genetic Enhancements: A Transhumanist Perspective.” Journal of Value Inquiry 37(4): 493-506. https://doi.org/10.1023/B:INQU.0000019037.67783.d5.
• Bostrom, Nick. 2005. “Transhumanist Values, Ethical Issues for the Twenty-First Century Pages.” Journal of Philosophical Research 30: 3-14. https://doi.org/10.5840/jpr_2005_26.
• Callaway, Ewen. 2014. “Reproductive medicine: The Power of Three.” Nature 509: 414-417. https://doi.org/10.1038/509414a.
• Chadwick, Ruth, and Mairi Levitt. 1998. “Genetic Technology: A Threat to Deafness.” Medicine, Health Care and Philosophy 1(3): 209-215. https://doi.org/10.1023/A:1009960924838.
• Chyrowicz, Barbara. 2004. “Spór o poprawianie ludzkiej natury.” W Etyka i technika w poszukiwaniu ludzkiej doskonałości, red. Barbara Chyrowicz, 47-61. Lublin: Towarzystwo Naukowe KUL.
• Cimadomo, Danilo, Antonio Capalbo, Filippo Maria Ubaldi, Catello Scarica, Antonio Palagiano, Rita Canipari, and Laura Rienzi. 2016. “The Impact of Biopsy on Human Embryo Developmental Potential during Preimplantation Genetic Diagnosis.” BioMed Research International. https://doi.org/10.1155/2016/7193075.
• Coleman, Mathew, and Kevin Grove. 2009. “Biopolitics, Biopower, and the Return of Sovereignty.” Environment and Planning, Society and Space 27(3): 489-507. https://doi.org/10.1068/d3508.
• Collins, Francis S. 1991. “Medical and Ethical Consequences of the Human Genome Project.” Journal of Clinical Ethics 2(4): 260-267.
• Conrad, Peter, and Joseph W. Schneider. 1980. “Looking at Levels of Medicalization. A Comment on Strong's Critique of the Thesis of Medical Imperialism.” Social Science and Medicine 14: 75-79. https://doi.org/10.1016/S0271-7123(80)90804-4.
• Conrad, Peter. 1992. “Medicalization and Social Control.” Annual Review of Sociology 18: 209-232. https://doi.org/10.1146/annurev.so.18.080192.001233.
• Cooke, Robert. 1978. Improving on Nature: The Brave New World of Genetic Engineering. New York: Quadrangle Books.
• Crawford, Robert. 1980. “Healthism and the Medicalization of Everyday Life.” International Journal of Health Services 10(3): 365-388. https://doi.org/10.2190/3H2H-3XJN-3KAY-G9NY.
• Domaradzki, Jan. 2012. “Genetyzacja społeczeństwa. Społeczne konsekwencje nowej genetyki.” Studia Socjologiczne 2(205): 7-26.
• Fedoruk, Matthew N., and Jim L. Rupert. 2008. “Myostatin Inhibition: a Potential Performance Enhancement Strategy?” Scandinavian Journal of Medicine & Science in Sports 18(2): 123-131. https://doi.org/10.1111/j.1600-0838.2007.00759.x.
• Fukuyama, Francis. 2002. Our Posthuman Future: Consequences of the Biotechnology Revolution. New York: Farrar, Straus and Giroux Publishing.
• Gunderson, Martin. 2008. “Genetic Engineering and the Consent of Future Persons.” Journal of Evolution and Technology 18(1): 86-93.
• Haisma, Hidde J., and Olivier de Hon. 2006. “Gene Doping.” International Journal of Sports Medicine 27: 257–266. https://doi.org/10.1055/s-2006-923986.
• Harris, John. 2007. Enhancing Evolution: The Ethical Case for Making Better People. Princeton: Princeton University Press.
• Hayashi, Rikimaru. 2002. Trends in High Pressure Bioscience and Biotechnology. Progress in Biotechnology. Kyoto: Elsevier Science.
• Hedgecoe, Adam M. 1998. “Geneticization, Medicalisation and Polemics.” Medicine, Health Care, and Philosophy 1(3): 235-243.
• Hertz, Rosanna. 2006. Single by Chance, Mothers by Choice: How Women are Choosing Parenthood without Marriage and Creating the New American Family. Oxford: Oxford University Press.
• Illich, Ivan. 1975. “The Medicalization of Life.” Journal of Medical Ethics 1(1): 73-77. http://dx.doi.org/10.1136/jme.1.2.73.
• Kass, Leon. 2002. Life, Liberty, and Defense of Dignity: The Challenge for Bioethics. San Francisco: Encounter Books.
• Kirby, David A. 2000. “The New Eugenics in Cinema: Genetic Determinism and Gene Therapy in GATTACA.” Science Fiction Studies 27: 193-215.
• Kirby, David A. 2004. “Extrapolating Race in GATTACA: Genetic Passing, Identity, and the Science of Race.” Literature and Medicine 23: 184-200. https://doi.org/10.1353/lm.2004.0006.
• Knowles, Lori P., and Gregory E. Kaebnick. 2007. Reprogenetics: Law, Policy, and Ethical Issues. Baltimore: The Johns Hopkins University Press.
• Kraj, Tomasz. 2010. Granice genetycznego udoskonalenia człowieka. Kraków: Wydawnictwo św. Stanisława BM.
• Leźnicki, Marcin. 2017. Bioetyka wobec klonowania reprodukcyjnego człowieka. Toruń: Wydawnictwo TAKO.
• Lippman, Abby. 1991. “Prenatal Genetic Testing and Screening: Constructing Needs and Reinforcing Inequities.” American Journal of Law and Medicine 1: 15-50.
• Lippman, Abby. 1992. “Led (Astray) by Genetic Maps: The Cartography of the Human Genome and Health Care.” Social Science and Medicine 35: 1469-1476.
• Lippman, Abby. 1993. “Prenatal Genetic Testing and Geneticization: Mother Matters for All.” Fetal Diagn Ther 8: 175-188.
• Liss, Joanna, Iwona Chromik, Joanna Szczyglińska, Monika Jagiełło, Aron Łukaszuk, and Krzysztof Łukaszuk. 2016. “Current methods for preimplantation genetic diagnosis.” Ginekologia Polska 87(7): 522-526. https://doi.org/10.5603/GP.2016.0037.
• Mancuso, Katherine, William W. Hauswirth, Qiuhong Li, Thomas B. Connor, James A. Kuchenbecker, Matthew C. Mauck, Jay Neitz, and Maureen Neitz. 2009. “Gene Therapy for Red–green Color Blindness in Adult Primates.” Nature 461: 784–787.
• https://doi.org/10.1038/nature08401.
• McConnell, Terrance. 2010. “Genetic Enhancement, Human Nature, and Rights.” The Journal of Medicine and Philosophy 35: 415-428. https://doi.org/10.1093/jmp/jhq034.
• McConnell, Terrance. 2010/2011. “Genetic intervention and the parentchild relationship.” Genomics, Society and Policy 6(3): 1-14.
• McPherron, Alexandra C., and Se-Jin Lee. 1997. “Double Muscling in Cattle Due to Mutations in the Myostatin Gene.” Proceedings of the National Academy of Science USA 94: 12457-12461. https://doi.org/10.1073/pnas.94.23.12457.
• McPherron, Alexandra C., Ann M. Lawler, and Se-Jin Lee. 1997. “Regulation of Skeletal Muscle Mass in Mice by a New TGF-β Superfamily Member.” Nature 387: 83-90. https://doi.org/10.1038/387083a0.
• Melo-Martin, Inmaculada (de). 2017. Rethinking Reprogenetics: Enhancing Ethical Analyses of Reprogenetic technologies. Oxford: Oxford University Press.
• Parens, Erik, and Lori P. Knowles. 2003. “Reprogenetics and Public Policy: Reflections and Recommendations.” The Hastings Center Report 33: 1-25.
• Plotz, David. 2006. The Genius Factory: The Curious History of the Nobel Prize Sperm Bank. New York: Random House.
• Rabinow, Paul, and Nikolas Rose. 2006. “Biopower Today.” Biosocieties 1(2): 195-217. https://doi.org/10.1017/S1745855206040014.
• Raman, Sujatha, and Richard Tutton. 2009. “Life, Science, and Biopower.” Science, Technology & Human Values 35(5): 711-734. https://doi.org/10.1177/0162243909345838.
• Ramsey, Paul. 1970. Fabricated Man: The Ethics of Genetic Control. New Haven: Yale University Press.
• Rasko, John, Gabrielle O’Sullivan, and Rachel Ankeny. 2006. The Ethics of Inheritable Genetic Modification: A Dividing Line? Cambridge: Cambridge University Press.
• Raz, Aviad E. 2009. “Eugenic Utopias/dystopias, Reprogenetics, and Community Genetics.” Foundation for the Sociology of Health & Illness 31: 602-616. https://doi.org/10.1111/j.1467-9566.2009.01160.x.
• Resnik, David B., and Daniel B. Vorhaus. 2006. “Genetic Modification and Genetic determinism.” Philosophy, Ethics, and Humanities in Medicine 1(9). https://doi.org/10.1186/1747-5341-1-9.
• Robertson, John A. 2001. “Human Embryonic Stem cell Research: Ethical and Legal Issues.” Nature Reviews Genetics 2: 74-78. https://doi.org/10.1038/35047594.
• Rose, Nikolas. 2007. “Beyond Medicalization.” Lancet 369: 700-701. https://doi.org/10.1016/S0140-6736(07)60319-5.
• Sandel, Michael. 2007. The Case Against Perfection: Ethics in the Age of Genetic Engineering. Cambridge: Harvard University Press.
• Savulescu, Julian, Ruud ter Meulen, and Guy Kahane. 2011. Enhancing Human Capacities. Oxford: Oxford University Press. https://doi.org/10.1002/9781444393552.
• Schjerling, Peter. 2008. “Gene Doping.” Scandinavian Journal of Medicine & Science in Sports 18(2): 121-122. https://doi.org/10.1111/j.1600-0838.2008.00806.x.
• Schuelke, Markus, Kathryn R. Wagner, Leslie E. Stolz, Christoph Hübner, Thomas Riebel, Wolfgang Kömen, Thomas Braun, James F. Tobin, and Se-Jin Lee. 2004. “Myostatin Mutation Associated with Gross Muscle Hypertrophy in a Child.” New England Journal of Medicine 350(26): 2682-2688. https://doi.org/10.1056/NEJMoa040933.
• Silver, Lee M. 2000. “Reprogenetics: Third Millennium Speculation. The Consequences for Humanity when Reproductive Biology Andgenetics are Combined.” EMBO Reports 1: 375-378. https://doi.org/10.1093/embo-reports/kvd096.
• Singer, Peter. 2009. “Parental Choice and Human Improvement.” In Human Enhancement, edited by Julian Savulescu, and Nick Bostrom, 277-289. Oxford - New York: Oxford University Press.
• Stock, Gregory. 2003. Redesigning Humans: Choosing our Genes, Changing our Future. New York: Mariner Books.
• Valerius, Karyn. 2011. “Genetic Essentialism: Race, Class and the Politics of Reproduction.” Consumption Markets & Culture 1: 229-247. https://doi.org/10.1080/10253866.1997.9670300.
• Weicker, Juliane, Arno Villringer, and Angelika Thöne-Otto. 2016. “Can Impaired Working Memory Functioning be Improved by Training? A Meta-Analysis with a Special Focus on Brain Injured Patients.” Neuropsychology 30(2): 190-212. https://doi.org/10.1037/neu0000227.
• Wilkinson, Stephen. 2010. Choosing Tomorrow’s Children: The Ethics of Selective Reproduction. New York: Oxford University Press. https://doi.org/10.1093/acprof:oso/9780199273966.001.0001.

Identifiers

DOI

10.21697/seb.2020.18.3.02